Is Targeting the Folate Receptor in Ovarian Cancer Coming of Age?

Por Birrer, Michael J., Betella, Ilaria, Martin, Lainie P., Moore, Kathleen N.
Publicado no Oncologist (2019)

Phase II Evaluation of Dalantercept in the Treatment of Persistent or Recurrent Epithelial Ovarian Cancer: an NRG Oncology/Gynecologic Oncology Group Study

Por Burger, Robert A., Deng, Wei, Makker, Vicky, Collins, Yvonne, Gray, Heidi, Debernardo, Robert, Martin, Lainie P., Aghajanian, Carol
Publicado no Gynecol Oncol (2018)

Phase II trial of nab-paclitaxel in the treatment of recurrent or persistent advanced cervix cancer: A gynecologic oncology group study

Por Alberts, David S., Blessing, John A., Landrum, Lisa M., Warshal, David P., Martin, Lainie P., Rose, Stephen L., Bonebrake, Albert J., Ramondetta, Lois M.
Publicado no Gynecol Oncol (2012)

A Phase II Evaluation of AMG 102 (Rilotumumab) In The Treatment Of Persistent Or Recurrent Epithelial Ovarian, Fallopian Tube Or Primary Peritoneal Carcinoma: A Gynecologic Oncolog...

Por Martin, Lainie P., Sill, Michael, Shahin, Mark S., Powell, Matthew, DiSilvestro, Paul, Landrum, Lisa M., Gaillard, Stephanie L., Goodheart, Michael J., Hoffman, James, Schilder, Russell J.
Publicado no Gynecol Oncol (2013)

Safety and Activity of Mirvetuximab Soravtansine (IMGN853), a Folate Receptor Alpha–Targeting Antibody–Drug Conjugate, in Platinum-Resistant Ovarian, Fallopian Tube, or Primary Per...

Por Moore, Kathleen N., Martin, Lainie P., O’Malley, David M., Matulonis, Ursula A., Konner, Jason A., Perez, Raymond P., Bauer, Todd M., Ruiz-Soto, Rodrigo, Birrer, Michael J.
Publicado no J Clin Oncol (2017)

Randomized Phase II Evaluation of Bevacizumab Versus Bevacizumab Plus Fosbretabulin in Recurrent Ovarian, Tubal, or Peritoneal Carcinoma: An NRG Oncology/Gynecologic Oncology Group...

Por Monk, Bradley J., Sill, Michael W., Walker, Joan L., Darus, Christopher J., Sutton, Gregory, Tewari, Krishnansu S., Martin, Lainie P., Schilder, Jeanne M., Coleman, Robert L., Balkissoon, Jai, Aghajanian, Carol
Publicado no J Clin Oncol (2016)

Network analysis identifies an HSP90-central hub susceptible in ovarian cancer

Por Liu, Hanqing, Xiao, Fang, Serebriiskii, Ilya G., O’Brien, Shane W., Maglaty, Marisa A., Astsaturov, Igor, Litwin, Samuel, Martin, Lainie P., Proia, David A., Golemis, Erica A., Connolly, Denise C.
Publicado em 2013

Relationships Among Financial Distress, Emotional Distress, and Overall Distress in Insured Patients With Cancer

Por Meeker, Caitlin R., Geynisman, Daniel M., Egleston, Brian L., Hall, Michael J., Mechanic, Karen Y., Bilusic, Marijo, Plimack, Elizabeth R., Martin, Lainie P., von Mehren, Margaret, Lewis, Bianca, Wong, Yu-Ning
Publicado no J Oncol Pract (2016)

CT perfusion as an early biomarker of treatment efficacy in advanced ovarian cancer: an ACRIN and GOG study

Por Ng, Chaan S, Zhang, Zheng, Lee, Susanna I, Marques, Helga S, Burgers, Kyle, Su, Feng, Bauza, Joseph, Mannel, Robert S, Walker, Joan L, Huh, Warner King, Rubin, Stephen C, DiSilvestro, Paul, Martin, Lainie P, Chan, John K, Bookman, Michael A, Coleman, Robert L, Lee, Ting-Yim
Publicado no Clin Cancer Res (2017)

Association of Ipilimumab With Safety and Antitumor Activity in Women With Metastatic or Recurrent Human Papillomavirus–Related Cervical Carcinoma

Por Lheureux, Stephanie, Butler, Marcus O., Clarke, Blaise, Cristea, Mihaela C., Martin, Lainie P., Tonkin, Katia, Fleming, Gini F., Tinker, Anna V., Hirte, Hal W., Tsoref, Daliah, Mackay, Helen, Dhani, Neesha C., Ghatage, Prafull, Weberpals, Johanne, Welch, Stephen, Pham, Nhu-An, Motta, Vinicius, Sotov, Valentin, Wang, Lisa, Karakasis, Katherine, Udagani, Smitha, Kamel-Reid, Suzanne, Streicher, Howard Z., Shaw, Patricia, Oza, Amit M.
Publicado no JAMA Oncol (2017)

Alisertib in Combination With Weekly Paclitaxel in Patients With Advanced Breast Cancer or Recurrent Ovarian Cancer: A Randomized Clinical Trial

Por Falchook, Gerald, Coleman, Robert L., Roszak, Andrzej, Behbakht, Kian, Matulonis, Ursula, Ray-Coquard, Isabelle, Sawrycki, Piotr, Duska, Linda R., Tew, William, Ghamande, Sharad, Lesoin, Anne, Schwartz, Peter E., Buscema, Joseph, Fabbro, Michel, Lortholary, Alain, Goff, Barbara, Kurzrock, Razelle, Martin, Lainie P., Gray, Heidi J., Fu, Siqing, Sheldon-Waniga, Emily, Lin, Huamao Mark, Venkatakrishnan, Karthik, Zhou, Xiaofei, Leonard, E. Jane, Schilder, Russell J.
Publicado no JAMA Oncol (2018)